Skip to Content

51 Results Found

  • Article
  • Open Access
10 Citations
4,083 Views
16 Pages

The Effect of Disulfiram and Copper on Cellular Viability, ER Stress and ALDH Expression of Human Meningioma Cells

  • Ying Kao,
  • Li-Chun Huang,
  • Shao-Yuan Hsu,
  • Shih-Ming Huang and
  • Dueng-Yuan Hueng

(1) Background: Meningiomas are the most common intracranial tumors in adults; currently there is no effective chemotherapy for malignant meningiomas. The effect of disulfiram (DSF)/Copper (Cu) on meningiomas remains unclear; (2) Methods: The impact...

(This article belongs to the Special Issue Molecular Research in Neurological and Psychiatric Disease)
  • Article
  • Open Access
199 Citations
11,379 Views
20 Pages

6 January 2020

Disulfiram/copper (DSF/Cu) is a promising antitumor reagent for clinical application due to its excellent anticancer activity and safety. However, the anticancer mechanism of DSF/Cu has not been fully elucidated. Our study showed that DSF/Cu strongly...

  • Article
  • Open Access
5 Citations
3,034 Views
12 Pages

In Situ Synthesis of a Tumor-Microenvironment-Responsive Chemotherapy Drug

  • Xiupeng Wang,
  • Ayako Oyane,
  • Tomoya Inose and
  • Maki Nakamura

Current chemotherapy still suffers from unsatisfactory therapeutic efficacy, multi-drug resistance, and severe adverse effects, thus necessitating the development of techniques to confine chemotherapy drugs in the tumor microenvironment. Herein, we f...

(This article belongs to the Special Issue Beyond the Platinum in Metal-Based Cancer Therapy, 2nd Edition)
  • Article
  • Open Access
5 Citations
2,128 Views
14 Pages

15 December 2023

Clinically, cancer chemotherapy still faces unsatisfactory efficacy due to drug resistance and severe side effects, including tiredness, hair loss, feeling sick, etc. The clinical benefits of checkpoint inhibitors have revived hope for cancer immunot...

  • Article
  • Open Access
21 Citations
4,783 Views
13 Pages

19 September 2019

Disulfiram has been used in the treatment of alcoholism and exhibits an anti-tumor effect. However, the intracellular mechanism of anti-tumor activity of Disulfiram remains unclear. In this study, we focused on the modulatory role of Disulfiram via o...

(This article belongs to the Collection Efficient Pharmaceutical and Chemical Approaches for Anticancer Therapy: Design, Preliminary Evaluations, and Further Developments)
  • Review
  • Open Access
55 Citations
8,528 Views
26 Pages

Advancing Cancer Therapy with Copper/Disulfiram Nanomedicines and Drug Delivery Systems

  • Xuejia Kang,
  • Sanika Jadhav,
  • Manjusha Annaji,
  • Chung-Hui Huang and ,
  • Rajesh Amin,
  • Jianzhong Shen,
  • Charles R. Ashby,
  • Amit K. Tiwari,
  • R. Jayachandra Babu and
  • Pengyu Chen
  • + 5 authors+ 0 author

Disulfiram (DSF) is a thiocarbamate based drug that has been approved for treating alcoholism for over 60 years. Preclinical studies have shown that DSF has anticancer efficacy, and its supplementation with copper (CuII) significantly potentiates the...

(This article belongs to the Special Issue Functionalized Nanoparticles in Cancer Therapeutics)
  • Article
  • Open Access
17 Citations
4,927 Views
16 Pages

Disulfiram Ophthalmic Solution Inhibited Macrophage Infiltration by Suppressing Macrophage Pseudopodia Formation in a Rat Corneal Alkali Burn Model

  • Toyo Ikebukuro,
  • Takeshi Arima,
  • Momoko Kasamatsu,
  • Yuji Nakano and ,
  • Yutaro Tobita,
  • Masaaki Uchiyama,
  • Yuya Terashima,
  • Etsuko Toda,
  • Akira Shimizu and
  • Hiroshi Takahashi
  • + 5 authors+ 0 author

FROUNT is an intracellular protein that promotes pseudopodia formation by binding to the chemokine receptors CCR2 and CCR5 on macrophages. Recently, disulfiram (DSF), a drug treatment for alcoholism, was found to have FROUNT inhibitory activity. In t...

(This article belongs to the Special Issue Molecular and Cellular Mechanisms of Corneal Fibrosis/Scarring and Advances in Therapy)
  • Article
  • Open Access
14 Citations
8,391 Views
14 Pages

16 August 2019

The inhibition of aldehyde dehydrogenase (ALDH) by disulfiram (DSF) in vitro can be prevented and/or reversed by dithiothreitol (DTT), which is a well-known low molecular weight non-physiological redox reagent commonly used in laboratory experiments....

(This article belongs to the Section Cellular Biochemistry)
  • Article
  • Open Access
5 Citations
7,563 Views
18 Pages

Effect of Disulfiram on the Reproductive Capacity of Female Mice

  • Mingming Teng,
  • Yuan Luo,
  • Chan Wang and
  • Anmin Lei

25 January 2023

In the process of assisted reproduction, the high-oxygen in vitro environment can easily cause oxidative damage to oocytes. Disulfiram (DSF) can play an anti-oxidant or pro-oxidant role in different cells, and the effect of DSF on oocytes remains unc...

(This article belongs to the Special Issue Central and Local Modulators of Reproduction and Fertility: An Update 2.0)
  • Article
  • Open Access
11 Citations
6,171 Views
20 Pages

Targeting Hyperuricemia and NLRP3 Inflammasome in Gouty Arthritis: A Preclinical Evaluation of Allopurinol and Disulfiram Combination Therapy

  • Yahya I. Asiri,
  • Manimekalai Pichaivel,
  • Selva Prasanthi Parameshwaran,
  • Krishnaraju Venkatesan and ,
  • Saud Alqahtani,
  • Taha Alqahtani,
  • Rehab Ahmed,
  • Hassabelrasoul Elfadil,
  • Mahmoud Elodemi and
  • Premalatha Paulsamy
  • + 7 authors+ 2 authors

Background/Objectives: Gouty arthritis (GA) is a chronic inflammatory condition characterized by hyperuricemia and NLRP3 inflammasome activation, leading to joint damage and systemic inflammation. Although allopurinol (ALP), a xanthine oxidase inhibi...

(This article belongs to the Section Pharmacology)
  • Article
  • Open Access
23 Citations
4,270 Views
21 Pages

Disulfiram Acts as a Potent Radio-Chemo Sensitizer in Head and Neck Squamous Cell Carcinoma Cell Lines and Transplanted Xenografts

  • Wenhao Yao,
  • Xu Qian,
  • Sebastian Ochsenreither,
  • Ferrone Soldano and ,
  • Albert B. DeLeo,
  • Holger Sudhoff,
  • Felix Oppel,
  • Andreas Kuppig,
  • Konrad Klinghammer and
  • Andreas E. Albers
  • + 6 authors+ 1 author

28 February 2021

The poor prognosis of locally advanced and metastatic head and neck squamous cell carcinoma (HNSCC) is primarily mediated by the functional properties of cancer stem cells (CSCs) and resistance to chemoradiotherapy. We investigated whether the aldehy...

(This article belongs to the Special Issue Molecular and Cellular Mechanisms of Cancers: Head and Neck Cancer)
  • Review
  • Open Access
486 Views
18 Pages

27 August 2026

Disulfiram (DSF), long used as an aversive agent in alcohol dependence therapy, has recently regained attention as a promising candidate for oncological drug repurposing. After administration, DSF is rapidly reduced to diethyldithiocarbamate (DDC), w...

(This article belongs to the Section Molecular Pharmacology)
  • Article
  • Open Access
78 Citations
5,821 Views
15 Pages

Disulfiram/Copper Induces Immunogenic Cell Death and Enhances CD47 Blockade in Hepatocellular Carcinoma

  • Xingxing Gao,
  • Hechen Huang,
  • Caixu Pan,
  • Zhibin Mei and ,
  • Shengyong Yin,
  • Lin Zhou and
  • Shusen Zheng
  • + 2 authors+ 0 author

28 September 2022

Some chemotherapeutic agents have been found to enhance antitumor immunity by inducing immunogenic cell death (ICD). The combination of disulfiram (DSF) and copper (Cu) has demonstrated anti-tumor effects in a range of malignancies including hepatoce...

(This article belongs to the Topic Advances in Anti-Cancer Drugs)
  • Article
  • Open Access
11 Citations
4,062 Views
14 Pages

Disulfiram (DSF) degrades to diethyldithiocarbamate (DTC) in vivo and coordinates with copper ions to form CuET, which has higher antitumor activity. In this study, DSF@CuMSN-PDA nanoparticles were prepared using mesoporous silica with copper ions, D...

(This article belongs to the Special Issue Anti-Cancer Drug Delivery Systems)
  • Article
  • Open Access
12 Citations
4,899 Views
17 Pages

Disulfiram Exerts Antifibrotic and Anti-Inflammatory Therapeutic Effects on Perimysial Orbital Fibroblasts in Graves’ Orbitopathy

  • Xing Wang,
  • Huijing Ye,
  • Shenglan Yang,
  • Xiaotong Sha and ,
  • Xiandai Wang,
  • Te Zhang,
  • Rongxin Chen,
  • Wei Xiao and
  • Huasheng Yang
  • + 4 authors+ 0 author

Fibrosis of extraocular muscles (EOMs) is a marker of end-stage in Graves’ orbitopathy (GO). To determine the antifibrotic and anti-inflammatory therapeutic effects and the underlying molecular mechanisms of disulfiram (DSF) on perimysial orbit...

(This article belongs to the Section Molecular Endocrinology and Metabolism)
  • Article
  • Open Access
7 Citations
3,709 Views
17 Pages

The Positive and Negative Outcome of Morphine and Disulfiram Subacute Co-Administration in Rats in the Absence of Ethanol Challenge

  • Karolina Frączek,
  • Agnieszka Kowalczyk,
  • Martyna Pekala,
  • Kaja Kasarello and ,
  • Grażyna Sygitowicz,
  • Dorota Sulejczak,
  • Malgorzata Zaremba,
  • Marek Konop,
  • Malgorzata Frankowska and
  • Patrycja Kleczkowska
  • + 7 authors+ 2 authors

Recently, a well-known anti-alcohol agent, disulfiram (DSF), has gain much interest, as it was found to be effective in the treatment of cocaine abusers, thus also giving hope for patients addicted to opioids and other illicit drugs. Therefore, this...

  • Article
  • Open Access
14 Citations
3,424 Views
10 Pages

Injectable Hydrogel for Cu2+ Controlled Release and Potent Tumor Therapy

  • Chunyu Huang,
  • Bei Chen,
  • Mingzhu Chen,
  • Wei Jiang and
  • Wei Liu

26 April 2021

Disulfiram (DSF) is an important drug for the treatment and management of alcohol dependency. This drug has been approved by US-FDA, and its activity against the tumor is dependent on copper ion (Cu2+). However, the copper toxicity (caused via extern...

(This article belongs to the Section Biochemistry, Biophysics and Computational Biology)
  • Article
  • Open Access
2 Citations
1,105 Views
16 Pages

Disulfiram/Copper Combined with Irradiation Induces Immunogenic Cell Death in Melanoma

  • Enwen Wang,
  • Yida Zhang,
  • Lin Jia,
  • Zunwen Lin and ,
  • Ting Sun,
  • Pan Hu,
  • Kun Wang,
  • Zikun Shang,
  • Wei Guo and
  • Xinhui Wang
  • + 6 authors+ 1 author

Immunogenic cell death (ICD) is a programmed pathway leading to cell death and promotion of immunological responses. Melanoma is resistant to chemotherapy and radiotherapy (RT). Disulfiram (DSF), which forms complexes with copper (Cu), has been shown...

(This article belongs to the Special Issue Molecular Research and New Therapy in Melanoma and Other Skin Cancers: 2nd Edition)
  • Article
  • Open Access
16 Citations
4,518 Views
21 Pages

Repurposing Disulfiram for Targeting of Glioblastoma Stem Cells: An In Vitro Study

  • Lisa Zirjacks,
  • Nicolai Stransky,
  • Lukas Klumpp,
  • Lukas Prause and ,
  • Franziska Eckert,
  • Daniel Zips,
  • Sabine Schleicher,
  • Rupert Handgretinger,
  • Stephan M. Huber and
  • Katrin Ganser
  • + 5 authors+ 0 author

21 October 2021

Mesenchymal glioblastoma stem cells (GSCs), a subpopulation in glioblastoma that are responsible for therapy resistance and tumor spreading in the brain, reportedly upregulate aldehyde dehydrogenase isoform-1A3 (ALDH1A3) which can be inhibited by dis...

(This article belongs to the Special Issue Repurposing Drugs for Anti-Cancer Therapy)
  • Review
  • Open Access
7 Citations
4,996 Views
10 Pages

Possible Therapeutic Potential of Disulfiram for Multiple Myeloma

  • Denisa Weiser Drozdkova and
  • Katerina Smesny Trtkova

3 June 2021

Multiple myeloma (MM) is a malignant disease of the plasma cells representing approximately 10% of all hemato-oncological diseases. Detection of the disease is most probable at around 65 years of age, and the average survival of patients is estimated...

(This article belongs to the Section Medical Oncology)
  • Article
  • Open Access
11 Citations
5,227 Views
16 Pages

Benefits and Toxicity of Disulfiram in Preclinical Models of Nephropathic Cystinosis

  • Anna Taranta,
  • Mohamed A. Elmonem,
  • Francesco Bellomo,
  • Ester De Leo and ,
  • Sara Boenzi,
  • Manoe J. Janssen,
  • Amer Jamalpoor,
  • Sara Cairoli,
  • Anna Pastore and
  • Francesco Emma
  • + 15 authors+ 10 authors

24 November 2021

Nephropathic cystinosis is a rare disease caused by mutations of the CTNS gene that encodes for cystinosin, a lysosomal cystine/H+ symporter. The disease is characterized by early-onset chronic kidney failure and progressive development of extra-rena...

(This article belongs to the Special Issue Cellular and Molecular Mechanisms of Nephropathic Cystinosis)
  • Article
  • Open Access
10 Citations
4,076 Views
18 Pages

Disulfiram Oxy-Derivatives Suppress Protein Retrotranslocation across the ER Membrane to the Cytosol and Initiate Paraptosis-like Cell Death

  • Marina Solovieva,
  • Yuri Shatalin,
  • Irina Odinokova,
  • Olga Krestinina and ,
  • Yulia Baburina,
  • Yana Lomovskaya,
  • Anton Pankratov,
  • Natalia Pankratova,
  • Olga Buneeva and
  • Vladimir Akatov
  • + 7 authors+ 2 authors

29 August 2022

Disulfiram (DSF) and its derivatives were here investigated as antineoplastic agents, and their important feature is the ability to influence the UPS. We have recently shown that hydroxocobalamin catalyzes the aerobic oxidation of diethyldithiocarbam...

(This article belongs to the Special Issue Membrane Permeability and Channels)
  • Article
  • Open Access
25 Citations
4,615 Views
14 Pages

Disulfiram/Copper Suppresses Cancer Stem Cell Activity in Differentiated Thyroid Cancer Cells by Inhibiting BMI1 Expression

  • Yung-Lun Ni,
  • Peng-Ju Chien,
  • Hung-Chia Hsieh,
  • Huan-Ting Shen and ,
  • Hsueh-Te Lee,
  • Shih-Ming Chen and
  • Wen-Wei Chang
  • + 2 authors+ 0 author

31 October 2022

Differentiated thyroid carcinomas (DTCs), which have papillary and follicular types, are common endocrine malignancies worldwide. Cancer stem cells (CSCs) are a particular type of cancer cells within bulk tumors involved in cancer initiation, drug re...

(This article belongs to the Special Issue Drug Repurposing for Cancer Therapies)
  • Article
  • Open Access
18 Citations
4,495 Views
23 Pages

Disulfiram Sensitizes a Therapeutic-Resistant Glioblastoma to the TGF-β Receptor Inhibitor

  • Chan-Chuan Liu,
  • Cheng-Lin Wu,
  • Meng-Xuan Lin,
  • Chun-I Sze and
  • Po-Wu Gean

28 September 2021

Despite neurosurgery following radiation and chemotherapy, residual glioblastoma (GBM) cells develop therapeutic resistance (TR) leading to recurrence. The GBM heterogeneity confers TR. Therefore, an effective strategy must target cancer stem cells (...

(This article belongs to the Special Issue Cancer Prevention with Molecular Target Therapies 2.0)
  • Article
  • Open Access
1 Citations
2,768 Views
20 Pages

18 March 2024

Disulfiram (DSF), an anti-alcoholism medicine, exerts treatment effects in patients suffering from persistent Borreliosis and also exhibits anti-cancer effects through its copper chelating derivatives and induction of oxidative stress in mitochondria...

  • Article
  • Open Access
38 Citations
4,730 Views
21 Pages

Differential Cytotoxicity Mechanisms of Copper Complexed with Disulfiram in Oral Cancer Cells

  • Ssu-Yu Chen,
  • Yung-Lung Chang,
  • Shu-Ting Liu,
  • Gunng-Shinng Chen and ,
  • Shiao-Pieng Lee and
  • Shih-Ming Huang
  • + 1 author+ 0 author

Disulfiram (DSF), an irreversible aldehyde dehydrogenase inhibitor, is being used in anticancer therapy, as its effects in humans are known and less adverse than conventional chemotherapy. We explored the potential mechanism behind the cytotoxicity o...

(This article belongs to the Section Biochemistry)
  • Article
  • Open Access
1 Citations
1,859 Views
17 Pages

Effects of Disulfiram and Copper in Combination with Temozolomide on Survival, Tumor Size and Autophagy Markers in an F98 Rat Glioma Model

  • Petros N. Karamanakos,
  • Maria Fouka,
  • Diamanto Aretha,
  • Eleftheria S. Panteli and ,
  • Ioannis Panopoulos,
  • Dimitris Kletsas,
  • Anna Goussia,
  • Alexandra Papoudou-Bai,
  • Argyro Zacharioudaki and
  • Apostolos Papalois
  • + 9 authors+ 4 authors

18 February 2026

Glioblastoma (GBM) is the most common and most aggressive malignant primary brain tumor in adults with a median survival of 15 months. One of the main factors responsible for the poor prognosis of GBM is resistance to treatment with temozolomide (TMZ...

(This article belongs to the Special Issue Molecular and Cellular Targets on Anticancer Research and Perspectives)
  • Review
  • Open Access
1 Citations
2,345 Views
15 Pages

24 January 2026

Disulfiram (DSF) is a well-established inhibitor of aldehyde dehydrogenases (ALDHs) and an FDA-approved drug for chronic alcoholism. DSF has gained attention as a versatile scaffold for drug repurposing. Its metabolite, diethyldithiocarbamate (DDTC),...

(This article belongs to the Section Medicinal Chemistry)
  • Review
  • Open Access
45 Citations
6,497 Views
20 Pages

Disulfiram as a Therapeutic Agent for Metastatic Malignant Melanoma—Old Myth or New Logos?

  • Francisco Meraz-Torres,
  • Sarah Plöger,
  • Claus Garbe,
  • Heike Niessner and
  • Tobias Sinnberg

27 November 2020

New therapeutic concepts such as anti-PD-1-based immunotherapy or targeted therapy with BRAF and MEK inhibitors have significantly improved the survival of melanoma patients. However, about 20% of patients with targeted therapy and up to 50% with imm...

(This article belongs to the Special Issue Advances in Malignant Melanoma)
  • Article
  • Open Access
696 Views
21 Pages

Disulfiram Alleviates Metabolic Dysfunction-Associated Steatohepatitis in Mice via Inhibiting Aurora Kinase A and Restoring Autophagy

  • Zixiong Zhou,
  • Xi Zeng,
  • Yuqi Guo,
  • Zhengyi Tan and ,
  • Xin Zhang,
  • Xuyang Liu,
  • Shuyu Zheng,
  • Wenwen Liu,
  • Haiyan Wang and
  • Jing Qi
  • + 5 authors+ 0 author

Metabolic dysfunction-associated steatohepatitis (MASH) is a severe, progressive liver disease lacking effective therapies. Disulfiram (DSF), an FDA-approved medication for alcohol dependence, exhibits diverse biological activities beyond its primary...

(This article belongs to the Special Issue Lipotoxicity in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Its Therapeutic Control)
  • Article
  • Open Access
10 Citations
4,224 Views
14 Pages

Stabilization of the c-Myc Protein via the Modulation of Threonine 58 and Serine 62 Phosphorylation by the Disulfiram/Copper Complex in Oral Cancer Cells

  • Gunng-Shinng Chen,
  • Ssu-Yu Chen,
  • Shu-Ting Liu,
  • Cheng-Chih Hsieh and ,
  • Shiao-Pieng Lee and
  • Shih-Ming Huang
  • + 1 author+ 0 author

15 August 2022

MYC has a short half-life that is tightly regulated through phosphorylation and proteasomal degradation. Many studies have claimed that treatment with disulfiram (DSF) with or without copper ions can cause cancer cell death in a reactive oxygen speci...

(This article belongs to the Special Issue Metallodrugs: Mechanisms of Action, Molecular Targets and Biological Activity 2.0)
  • Article
  • Open Access
18 Citations
3,692 Views
21 Pages

26 August 2024

Lenvatinib resistance (LenR) presents a significant challenge in hepatocellular carcinoma (HCC) treatment, leading to high cancer-related mortality rates globally. Unlike traditional chemotherapy resistance mechanisms, LenR in HCC is primarily driven...

(This article belongs to the Section Circular and Green Sustainable Polymer Science)
  • Article
  • Open Access
30 Citations
3,866 Views
17 Pages

Disulfiram/Cu Kills and Sensitizes BRAF-Mutant Thyroid Cancer Cells to BRAF Kinase Inhibitor by ROS-Dependently Relieving Feedback Activation of MAPK/ERK and PI3K/AKT Pathways

  • Jingyi Xie,
  • Juan Liu,
  • Man Zhao,
  • Xinru Li and ,
  • Yubo Wang,
  • Yuelei Zhao,
  • Hongxin Cao,
  • Meiju Ji,
  • Mingwei Chen and
  • Peng Hou
  • + 5 authors+ 0 author

8 February 2023

BRAFV600E, the most common genetic alteration, has become a major therapeutic target in thyroid cancer. Vemurafenib (PLX4032), a specific inhibitor of BRAFV600E kinase, exhibits antitumor activity in patients with BRAFV600E-mutated thyroid cancer. Ho...

(This article belongs to the Section Molecular Oncology)
  • Article
  • Open Access
3 Citations
2,859 Views
22 Pages

The Effect of Disulfiram and N-Acetylcysteine, Potential Compensators for Sulfur Disorders, on Lipopolysaccharide-Induced Neuroinflammation Leading to Memory Impairment and the Metabolism of L-Cysteine Disturbance

  • Małgorzata Iciek,
  • Anna Bilska-Wilkosz,
  • Magdalena Górny,
  • Marek Bednarski and ,
  • Małgorzata Zygmunt,
  • Anthea Miller,
  • Noemi Nicosia,
  • Giorgia Pia Lombardo,
  • Paula Zammit and
  • Magdalena Kotańska
  • + 5 authors+ 0 author

27 January 2025

Background: The role of sulfur-containing drugs, disulfiram (DSF) and N-acetylcysteine (NAC), in alleviating neuroinflammation is poorly understood. The objective of this study was to examine the effect of DSF and NAC on memory and on the metabolism...

  • Article
  • Open Access
590 Views
24 Pages

Development and Characterization of a Hydrogel Incorporating Protamine–Hyaluronic Acid Nanoparticles Co-Loaded with Disulfiram and Coumarin for Diabetic Wound Healing

  • Zainab Lafi,
  • Mohammad I. A. Ahmad,
  • Shreen Deeb Nusair,
  • Razan Madi and ,
  • Alaa Al-Sanabrah,
  • Somaya Ahmad,
  • Qout Qtashat,
  • Maisrh Ali Alrubaye and
  • Sara Yousef Asha
  • + 4 authors+ 0 author

Background: Diabetes-associated wound healing is frequently impaired due to persistent hyperglycemia, which causes vascular dysfunction and neuropathy, thereby delaying tissue repair. Objectives: In this study, hyaluronic acid and protamine nanoparti...

(This article belongs to the Topic Advanced Biomaterials for Wound Healing: From Design to Application)
  • Article
  • Open Access
4 Citations
5,496 Views
11 Pages

Antimicrobial Activity of N,N-Diethyldithiocarbamate against Ureaplasma parvum and Ureaplasma urealyticum

  • Małgorzata Biernat-Sudolska,
  • Danuta Rojek-Zakrzewska,
  • Kamil Drożdż and
  • Anna Bilska-Wilkosz

Ureaplasma species (Ureaplasma spp.) are commonly found as commensals in the human urogenital tracts, although their overgrowth can lead to infection in the urogenital tract and at distal sites. Furthermore, ureaplasmas lack a cell wall and do not sy...

(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)
  • Article
  • Open Access
41 Citations
6,774 Views
16 Pages

Disulfiram (Antabuse) Activates ROS-Dependent ER Stress and Apoptosis in Oral Cavity Squamous Cell Carcinoma

  • Priyanka Shah O’Brien,
  • Yue Xi,
  • Justin R. Miller,
  • Amy L. Brownell and ,
  • Qinghua Zeng,
  • George H. Yoo,
  • Danielle M. Garshott,
  • Matthew B. O’Brien,
  • Anthony E. Galinato and
  • Andrew M. Fribley
  • + 9 authors+ 4 authors

A paucity of advances in the development of novel therapeutic agents for squamous cell carcinomas of the head and neck, oral cavity (OSCC) and oropharynx, has stagnated disease free survival rates over the past two decades. Although immunotherapies t...

(This article belongs to the Section Oncology)
  • Feature Paper
  • Article
  • Open Access
3,818 Views
13 Pages

Inhibition of Urea Hydrolysis in Human Urine for Resource and Energy Recovery: Pharmaceuticals and Their Metabolites as Co-Existing Anticatalyzers

  • Haoran Chi,
  • Minshu Chen,
  • Wei Yang,
  • Ya Li and ,
  • Shuhui Sun,
  • Hualin Wang,
  • Xuejing Yang,
  • Michael R. Hoffmann and
  • Lei Guo
  • + 4 authors+ 0 author

27 June 2025

Urine, which has a high concentration of urea, can be used as a sustainable resource for nutrient recovery and sustainable energy. However, urea undergoes hydrolysis, catalyzed by urease, generating ammonia and carbon dioxide. As ammonia is released...

(This article belongs to the Special Issue Enzyme Catalysis: Innovations and Applications in Sustainable Chemistry)
  • Article
  • Open Access
13 Citations
2,641 Views
16 Pages

Building of CuO2@Cu-TA@DSF/DHA Nanoparticle Targets MAPK Pathway to Achieve Synergetic Chemotherapy and Chemodynamic for Pancreatic Cancer Cells

  • Jiaru Zhang,
  • Zuoping Li,
  • Zhenzhen Xie,
  • Shiwan You and ,
  • Yanbing Chen,
  • Yuling Zhang,
  • Jing Zhang,
  • Na Zhao,
  • Xiling Deng and
  • Shiguo Sun
  • + 5 authors+ 0 author

Background/Objectives: With the increase of reactive oxygen species (ROS) production, cancer cells can avoid cell death and damage by up-regulating antioxidant programs. Therefore, it will be more effective to induce cell death by using targeted stra...

(This article belongs to the Section Drug Delivery and Controlled Release)
  • Article
  • Open Access
24 Citations
4,698 Views
15 Pages

16 April 2022

Epithelial ovarian cancer (EOC) is the leading cause of gynecological cancer-related death. The high mortality and morbidity associated with EOC are mostly due to late diagnosis and chemotherapy drug resistance. Currently, the standard first-line che...

  • Article
  • Open Access
13 Citations
4,990 Views
26 Pages

Isothiocyanates (ITCs) 1-(Isothiocyanatomethyl)-4-phenylbenzene and 1-Isothiocyanato-3,5-bis(trifluoromethyl)benzene—Aldehyde Dehydrogenase (ALDH) Inhibitors, Decreases Cisplatin Tolerance and Migratory Ability of NSCLC

  • Jolanta Kryczka,
  • Jakub Kryczka,
  • Łukasz Janczewski,
  • Anna Gajda and ,
  • Andrzej Frączyk,
  • Joanna Boncela,
  • Beata Kolesińska and
  • Ewa Brzeziańska-Lasota
  • + 3 authors+ 0 author

One of the main treatment modalities for non-small-cell lung cancer (NSCLC) is cisplatin-based chemotherapy. However, the acquisition of cisplatin resistance remains a major problem. Existing chemotherapy regimens are often ineffective against cancer...

(This article belongs to the Special Issue Strategies to Improve Antineoplastic Activity of Drugs in Cancer Progression)
  • Article
  • Open Access
39 Citations
7,421 Views
18 Pages

Targeting the NPL4 Adaptor of p97/VCP Segregase by Disulfiram as an Emerging Cancer Vulnerability Evokes Replication Stress and DNA Damage while Silencing the ATR Pathway

  • Dusana Majera,
  • Zdenek Skrott,
  • Katarina Chroma,
  • Joanna Maria Merchut-Maya and ,
  • Martin Mistrik and
  • Jiri Bartek
  • + 1 author+ 0 author

18 February 2020

Research on repurposing the old alcohol-aversion drug disulfiram (DSF) for cancer treatment has identified inhibition of NPL4, an adaptor of the p97/VCP segregase essential for turnover of proteins involved in multiple pathways, as an unsuspected can...

(This article belongs to the Special Issue Killing Cancer: Discovery and Selection of New Target Molecules)
  • Article
  • Open Access
1 Citations
1,765 Views
20 Pages

Novel Disulfiram-Loaded Metal–Organic Nanoparticles Inhibit Tumor Growth and Induce Immunogenic Cell Death of Triple-Negative Breast Cancer Cells

  • Chung-Hui Huang,
  • Xuejia Kang,
  • Lang Zhou,
  • Junwei Wang and ,
  • Shuai Wu,
  • Peizhen Sun,
  • Qi Wang,
  • Adam B. Keeton,
  • Pengyu Chen and
  • Gary A. Piazza
  • + 5 authors+ 0 author

Background/Objectives: Triple-negative breast cancer (TNBC) is among the most aggressive subtypes, lacking estrogen, progesterone, and HER2 receptors, which limits the efficacy of targeted therapies. Standard treatments often fail due to rapid drug r...

(This article belongs to the Section Drug Delivery and Controlled Release)
  • Article
  • Open Access
9 Citations
2,912 Views
21 Pages

Design and Characterization of Chitosan-Based Smart Injectable Hydrogel for Improved Sustained Release of Antinarcotics

  • Maryam Aftab,
  • Fatima Javed,
  • Sajjad Haider,
  • Rawaiz Khan and ,
  • Salah Uddin Khan,
  • Kamran Alam,
  • Afreenish Amir,
  • Faheem Ullah and
  • Naseer Ali Shah
  • + 4 authors+ 0 author

The treatment adherence of narcotics-addicted individuals with reduced incidences of relapse can be enhanced by a sustained drug release formulation of antinarcotics. So far, different drug formulations have been reported with sustained drug release...

(This article belongs to the Section Biopharmaceuticals)
  • Article
  • Open Access
17 Citations
3,756 Views
18 Pages

Homotype-Targeted Biogenic Nanoparticles to Kill Multidrug-Resistant Cancer Cells

  • Imran Shair Mohammad,
  • Birendra Chaurasiya,
  • Xuan Yang,
  • Chuchu Lin and ,
  • Hehui Rong and
  • Wei He
  • + 1 author+ 0 author

“Off-targeting” and receptor density expressed at the target sites always compromise the efficacy of the nanoparticle-based drug delivery systems. In this study, we isolated different cell membranes and constructed cell membrane-cloaked b...

  • Article
  • Open Access
8 Citations
3,905 Views
18 Pages

High systemic stability and effective tumor accumulation of chemotherapeutic agents are indispensable elements that determine their antitumor efficacy. PEGylation of nanoparticles (NPs) could prolong the retention time in vivo by improving their stab...

(This article belongs to the Special Issue Advances in Stimuli-Responsive Tumor Targeting Nanotechnology)
  • Communication
  • Open Access
3 Citations
1,741 Views
9 Pages

Sugar-Linked Diethyldithiocarbamate Derivatives: A Novel Class of Anticancer Agents

  • Mohammad Najlah,
  • Niamh McCallum,
  • Ana Maria Pereira,
  • Dan Alves and ,
  • Niusha Ansari-Fard,
  • Sahrish Rehmani and
  • Ayşe Kaya
  • + 2 authors+ 0 author

Disulfiram (DSF), a well-known anti-alcoholism drug, exhibits potent anticancer activity via its metabolite, diethyldithiocarbamate (DDC), which forms a cytotoxic copper complex that selectively targets cancer stem cells. However, its clinical utilit...

(This article belongs to the Section Molecular Pharmacology)
  • Article
  • Open Access
20 Citations
8,016 Views
21 Pages

Vitamin B12b Enhances the Cytotoxicity of Diethyldithiocarbamate in a Synergistic Manner, Inducing the Paraptosis-Like Death of Human Larynx Carcinoma Cells

  • Marina Solovieva,
  • Yuri Shatalin,
  • Roman Fadeev,
  • Olga Krestinina and ,
  • Yulia Baburina,
  • Alexey Kruglov,
  • Ekaterina Kharechkina,
  • Margarita Kobyakova,
  • Vadim Rogachevsky and
  • Vladimir Akatov
  • + 6 authors+ 1 author

1 January 2020

We have shown that hydroxycobalamin (vitamin B12b) increases the toxicity of diethyldithiocarbamate (DDC) to tumor cells by catalyzing the formation of disulfiram (DSF) oxi-derivatives. The purpose of this study was to elucidate the mechanism of tumo...

  • Article
  • Open Access
11 Citations
3,462 Views
14 Pages

Disulfiram Enhances the Antineoplastic Activity and Sensitivity of Murine Hepatocellular Carcinoma to 5-FU via Redox Management

  • Iftekhar Hassan,
  • Hossam Ebaid,
  • Ibrahim M. Alhazza,
  • Jameel Al-Tamimi and
  • Ahmed M. Rady

23 January 2023

The efficacy of anticancer drug 5-FU is suppressed due to various factors, including severe side effects and decreased insensitivity during prolonged chemotherapy. Elevated endogenous copper (Cu) levels are one of the prominent hallmark features of c...

(This article belongs to the Section Medicinal Chemistry)
  • Feature Paper
  • Article
  • Open Access
3 Citations
3,480 Views
14 Pages

Exposure to the Dioxin-like Pollutant PCB 126 Afflicts Coronary Endothelial Cells via Increasing 4-Hydroxy-2 Nonenal: A Role for Aldehyde Dehydrogenase 2

  • Bipradas Roy,
  • Zhao Yang,
  • Guodong Pan,
  • Katherine Roth and ,
  • Manisha Agarwal,
  • Rahul Sharma,
  • Michael C. Petriello and
  • Suresh Selvaraj Palaniyandi
  • + 3 authors+ 0 author

16 June 2022

Exposure to environmental pollutants, including dioxin-like polychlorinated biphenyls (PCBs), play an important role in vascular inflammation and cardiometabolic diseases (CMDs) by inducing oxidative stress. Earlier, we demonstrated that oxidative st...

(This article belongs to the Section Toxicology)

of 2